K
Kabra Drugs
KABRADG Share Price
Healthcare30.54
as on 27 Feb 2026 at 15:26
BSE
Market Cap
₹72 Cr
PE Ratio
16.10
ROCE
-4.40%
KABRADG Fundamentals
Company Valuation
Market Cap (₹ Cr.)
72
PE Ratio
16.10
PB Ratio
2.65
Dividend Yield
-
ROE
-4.40%
ROCE
-4.40%
Book Value (₹)
10.96
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 96.12% | 95.94% | 95.61% | 95.00% | 91.43% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
KABRADG Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524322
NSE Scrip Name
KABRADG
ISIN
INE323K01017



